Serotonin–norepinephrine releasing agent

Further information: serotonin releasing agent and norepinephrine releasing agent

A serotonin–norepinephrine releasing agent (SNRA) is a type of drug which induces the release of serotonin and norepinephrine (and epinephrine) in the body and/or brain.

MDAI, an SNRA.

MBDB, an SNRA.

Norfenfluramine, an SNRA.

Only a few SNRAs are known, examples of which include norfenfluramine, (R)-MDMA, MBDB, and MDAI. Fenfluramine produces norfenfluramine as a major active metabolite and hence is an SNRA similarly. It was formerly used as an appetite suppressant for the treatment of obesity. (R)-MDMA, MBDB, and MDAI are entactogens.

A closely related type of drug is a serotonin–norepinephrine reuptake inhibitor (SNRI).

Mechanism of action

Main article: Monoamine releasing agent § Mechanism of action

See also

• Monoamine releasing agent
• Serotonin releasing agent
• Norepinephrine releasing agent
• Serotonin–dopamine releasing agent
• Serotonin–norepinephrine–dopamine releasing agent